Cleared Traditional

K924666 - INTELECT IFC2

K924666 is an FDA 510(k) clearance for INTELECT IFC2, manufactured by Chattanooga Group, Inc.. The device is a Class 2 Neurology device with product code LIH cleared through the Traditional 510(k) pathway after a 170-day FDA review.

K924666 · Chattanooga Group, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1993
Decision
170d
Days
Class 2
Risk

K924666 is an FDA 510(k) clearance for the INTELECT IFC2. Classified as Interferential Current Therapy (product code LIH), Class II - Special Controls.

Submitted by Chattanooga Group, Inc. (Hixson, US). The FDA issued a Cleared decision on March 5, 1993 after a review of 170 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Chattanooga Group, Inc. devices

FDA 510(k) Submission Details - K924666

510(k) Number K924666 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 16, 1992
Decision Date March 05, 1993
Days to Decision 170 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d slower than avg
Panel avg: 148d · This submission: 170d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LIH Device Classification - Class 2, Special Controls

Product Code LIH Interferential Current Therapy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - LIH Interferential Current Therapy

All 21
Devices cleared under the same product code (LIH) and FDA review panel - the closest regulatory comparables to K924666.
ISOTRON III
K941815 · Excel Tech. , Ltd. · May 1995
THERATOUCH 4.7
K932868 · Rich-Mar Corp. · Jul 1994
INTERFERENTIAL STIMULATOR MODEL IMF4150/A
K925687 · Biomedical Life Systems, Inc. · Mar 1993
ENDOMED 582
K922020 · Henley Intl. · Sep 1992
MULTI III
K921953 · Excel Tech. , Ltd. · Aug 1992
ISOTRON III
K921954 · Excel Tech. , Ltd. · Aug 1992